『FDA Approves Label Supplement for iDose TR』のカバーアート

FDA Approves Label Supplement for iDose TR

FDA Approves Label Supplement for iDose TR

無料で聴く

ポッドキャストの詳細を見る

概要

The FDA approves a key label supplement for Glaukos’ iDoseTR; Nidek announces the European launch of a new open-field refraction system; and there have been several leadership changes announced during the first month of 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices
まだレビューはありません